Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820685 · ClinicalTrials.gov registry record · Phase 4
Dronabinol On the Pain Experience
A Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 484
- Enrollment target
NCT05820685: Clinical Trial Phase 4 study, sponsored by The University of Texas Health Science Center, Houston.
NCT05820685 is a Phase 4 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 484 participants, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05820685, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 484 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the effect dronabinol has on opioid exposure when used as an adjunct to the current standard multi-modal pain regimen (MMPR)
Primary Outcome
This will be calculated by calculated by taking the total of MMEs from all opioids received and dividing by length of stay
Interventions
- DRUG Dronabinol
- DRUG Standard of Care (acetaminophen +naproxen +gabapentin + as needed oxycodone or Tramadol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 484 participants |
| Start Date | 2023-07-27 |
| Est. Completion | 2024-04-29 |
| Phase | Phase 4 |
Why NCT05820685 stopped before completion
NCT05820685 is an interventional study that assigns participants to a tested intervention. The registered 484 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Dronabinol is the first listed.
NCT05820685 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05820685 about?
NCT05820685 is a clinical study titled "Dronabinol On the Pain Experience". The purpose of this study is to identify the effect dronabinol has on opioid exposure when used as an adjunct to the current standard multi-modal pain regimen (MMPR)
What is the current status of trial NCT05820685?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 484 participants. The study started on 2023-07-27. Estimated completion is 2024-04-29.
What interventions are being tested in trial NCT05820685?
The interventions under investigation include: Dronabinol (DRUG), Standard of Care (acetaminophen +naproxen +gabapentin + as needed oxycodone or Tramadol) (DRUG).
Who is sponsoring clinical trial NCT05820685?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05820685's enrollment target sits among peer trials
484 180th of 2000 higher than 1,820 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05421741 · 484 participants · Phase 4
Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- NCT07124910 · 485 participants · Phase 3
Comparison of Epi-ON Corneal Collagen Crosslinking Performed Using an 18-Minute UVA Exposure vs. a 24-Minute UVA Exposure on Eyes With Ectatic Corneal Diseases
- NCT02871726 · 483 participants · NA
Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- NCT06420531 · 486 participants · NA
Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI